Clinical and hemodynamic characterization of acute unstable angina associated with metabolic syndrome

Authors

Keywords:

unstable angina; metabolic syndrome; cardiovascular risk factors; cardiovascular complications; risk stratification

Abstract

Abstract

Introduction: Cardiovascular diseases are the leading cause of morbidity and mortality worldwide. Metabolic syndrome is an important cluster of risk factors that increases the likelihood of acute cardiovascular events.

Objective: To describe the clinical and hemodynamic characteristics of patients with unstable angina with electrocardiographic changes associated with metabolic syndrome.

Methods: A cross-sectional descriptive study was conducted in 1,912 patients admitted with unstable angina in the Cardiology service of Carlos Manuel de Céspedes Hospital, Bayamo, Cuba, between January 2020 and May 2022. Clinical, electrocardiographic, echocardiographic, and biochemical data were collected. Descriptive statistical techniques and SPSS 25.0 software were used for data analysis.

Results: The prevalence of MS was 30.2 %. Males predominated (58.5 %) with a mean age of 62.1 ± 8.6 years. In females, the prevalence of age ≥ 65 years, dyslipidemia, obesity, diabetes mellitus, and left ventricular dysfunction was higher, whereas smoking, left ventricular hypertrophy, and hypertensive cardiopathy were more frequent in males. The most common electrocardiographic abnormalities were mixed ST-T changes, T wave inversion, and ST segment depression. The most frequent complications were recurrent and refractory chest pain and heart failure.

Conclusions: These results demonstrate a significant association between metabolic syndrome and a more complex clinical presentation with severe cardiovascular complications. Implementation of comprehensive prevention strategies and development of predictive tools are recommended to improve clinical management and prognosis in these patients.

Downloads

Download data is not yet available.

Author Biographies

Julio Alberto Pérez Domínguez, Hos`pital Carlos Manuel de Céspedes

Doctor en Ciencias Médicas

Máster en Ciencias Médicas

Especialista de II grado en Cardiologia

Especialista de I grado en Medicina Interna

Especialista de II grado en Medicina Intensiva y Emergencia

Profesor e investigador titular

Jefe de cátedra docente de Cardiología

Presidente del Capitulo Granma de la Sociedad Cubana de Cardiología

Orlando Santiago Aguilar Almaguer , Hospital Carlos manuel de Céspedes

Especialista de I grado en Cardiología

Especialista de I grado en Medicina General Integral

Profesor instructor

José Alberto Sánchez Guerra, Hospital Carlos Manuel de Céspedes

Especialista de I grado en Cardiología

Profesor asistente

Investigador agregado

Alfredo Leyva Rodriguez, Hospital Carlos Manuel de Céspedes

Especialista de I grado en Cardiología

Especialista de I grado en Medicina General Integral

Profesor instructor

References

Referencias bibliográficas

1. Safiri S, Karamzad A, Sinngh K, Carson-Chahhoud K, Adams C, Nejadghaderi S, et al. Burden of ischemic heart disease and its attributable risk factor in 204 countries and territories, 1990-2019. Eur J Prev Cardiol. 2022; 29(2): 420-431. DOI: 10.1093/eurjpc/zwab213

2. Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart Disease and Stroke Statistics-2022 Update: a report from the American Heart Association. Circulation. 2022;145(8): e153-e639.

DOI:10.1161/CIR.0000000000001052

3. Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST. Rev Esp Cardiol. 2021; 74(6): 436.e1–436.e73. DOI: 10.1016/j.recesp.2020.12.024

4. Keykhaei M, Ashraf H, Rashedi S, Farrokhpour H, Heidari B, Zokaei S, et al. Differences in the 2020 ESC versus 2015 ESC and 2014 ACC/AHA Guidelines on the Management of Acute Coronary Syndromes in patients presenting without persistent ST-Segment elevation. Curr Atheroscler Rep. 2021; 23(12):77. DOI: 10.1007/s11883-021-00976-7

5. Andersson, C., Johnson, A.D., Benjamin, E.J, Levy D, Vasan RS. 70-year legacy of the Framingham Heart Study. Nat Rev Cardiol 2019; 16 (1): 687–698.

https://doi.org/10.1038/s41569-019-0202-5

6. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607. https://doi.org/10.2337/diab.37.12.1595

7. The Third Report National Colesterol Education Program (NCEP-ATPIII. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486–2497. DOI:10.1001/jama.285.19.2486

8. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022; 23(2):786. DOI: 10.3390/ijms23020786

9. Saklayen M.G. The global epidemic of the metabolic syndrome. Curr. Hypertens. Rep. 2018; 20:1–8. DOI: 10.1007/s11906-018-0812-z.

10. Cohen MG, Roe MT, Mulgund J, Peterson ED, Sonel AF, Menon V, et al. Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE). Am Heart J. 2020; 152(1):110-117. DOI:10.1016/j.ahj.2005.09.003

11. Silveira Rossi JL, Barbalho SM, Reverete de Araujo R, Bechara MD, Sloan KP, Sloan LA. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors. Diabetes Metab Res Rev. 2022; 38(3):e3502. DOI:10.1002/dmrr.3502

12. Aksoy S, Öz D, Öz M, Agirbasli M. Predictors of Long-Term Mortality in Patients with Stable Angina Pectoris and Coronary Slow Flow. Medicina (Kaunas). 2023; 59(4):763. DOI: 10.3390/medicina59040763

13. Elbarouni B, Goodman SG, Yan RT, Welsh RC, Kornder JM, Deyoung JP, et al. Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada. Am Heart J. 2009; 158(3):392-399. DOI: 10.1016/j.ahj.2009.06.010

14. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2020; 333(7578):1091.

DOI:10.1136/bmj.38985.646481.55

15. Código de Núremberg (1946). Observatori de Bioética i Dret. Parc Cientific de Barcelona. 2008. [acceso 25/08/2025]. Disponible en:

http://www.pcb.ub.es/bioeticaidret/archivos/norm/CodigoNuremberg.pdf

16. Declaración de Helsinki de la Asociación Médica Mundial (AMM). Principios éticos para las investigaciones médicas en seres humanos. Asociación Médica Mundial. WMA. 2017. [acceso 25/08/2025]. Disponible en:

https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/

17. Valdés-Ramos E, Álvarez-Aliaga A. Factores asociados al riesgo de desarrollar cardiopatía isquémica en personas con diabetes mellitus. Revista Cubana de Endocrinología [Internet]. 2023 [citado 24 Ago 2025]; 33 (3) Disponible en:

https://revendocrinologia.sld.cu/index.php/endocrinologia/article/view/364

18. Pérez Domínguez JA, Boza Torres PE, del Castillo Sánchez I, Cervantes Castro LF, Sánchez Sidenko A, Pérez Oliva A. Evaluación pronóstica del síndrome coronario agudo en pacientes con síndrome metabólico. MULTIMED [Internet]. 2019 Ago [citado 24 Ago 2025]; 23(4): 685-698. Disponible en:

http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1028-48182019000400685&lng=es.

19. Bhatt DL, Lopes RD, Harrington RA. Diagnosis and Treatment of Acute Coronary Syndromes: A Review. JAMA. 2022; 327(7):662-675.

DOI:10.1001/jama.2022.0358

20. Bovolini A, Garcia J, Andrade MA, Duarte JA. Metabolic Syndrome Pathophysiology and Predisposing Factors. Int J Sports Med. 2021; 42(3):199-214. DOI: 10.1055/a-1263-0898

21. Santilli F, D'Ardes D, Guagnano MT, Davi G. Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach. Curr Med Chem. 2021; 24(24):2602-2627. DOI: 10.2174/0929867324666170710131245

22. Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022; 399(10332):1347-1358

DOI: 10.1016/S0140-6736(21)02391-6

Published

2025-09-19

How to Cite

1.
Moreno Aliaga DY, Pérez Domínguez JA, Aguilar Almaguer OS, Sánchez Guerra JA, Leyva Rodriguez A. Clinical and hemodynamic characterization of acute unstable angina associated with metabolic syndrome. RM [Internet]. 2025 Sep. 19 [cited 2025 Oct. 5];29:e3206. Available from: https://revmultimed.sld.cu/index.php/mtm/article/view/3206

Issue

Section

ARTÍCULOS ORIGINALES